Osaka, Japan

Takahiko Nakao

This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takahiko Nakao. Retrieved from https://idiyas.com/inventor/takahiko-nakao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takahiko Nakao: Innovator in Pharmaceutical Chemistry

Introduction: Takahiko Nakao is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that exhibit therapeutic potential. His work has been recognized for its impact on medical science and drug development.

Latest Patents: Takahiko Nakao holds a patent for Phenylalkan(en)oic acid. This compound, as defined in the specification, possesses an antagonistic activity on leukotriene B.sub.4. His innovative approach to this chemical structure has opened new avenues for research and potential therapeutic applications.

Career Highlights: Nakao is associated with Ono Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His role at the company has allowed him to engage in cutting-edge research and development, contributing to the advancement of medical treatments.

Collaborations: Throughout his career, Takahiko Nakao has collaborated with notable colleagues, including Nobuyuki Hamanaka and Mitoshi Konno. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion: Takahiko Nakao's contributions to pharmaceutical chemistry exemplify the importance of innovation in medical science. His work continues to influence the development of new therapeutic agents, showcasing the vital role of inventors in advancing healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…